Letter to the Editor: Medications promoting abstinence in alcohol-associated cirrhosis

被引：0
|
作者：
Braillon, Alain
Naudet, Florian [1 ,2 ]
机构：
[1] Univ Rennes, Clin Invest Ctr, Ctr Clin Invest Rennes, Rennes, France
[2] Univ Rennes, Ctr Clin Invest Rennes, Adult Psychiat Dept, Rennes, France
来源：
HEPATOLOGY | 2024年 / 79卷 / 03期
关键词：
D O I：
10.1097/HEP.0000000000000656
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：E99 / E99
页数：1
相关论文
共 50 条
  • [1] Reply: Medications promoting abstinence in alcohol-associated cirrhosis
    Gratacos-Gines, Jordi
    Lopez-Pelayo, Hugo
    Pose, Elisa
    HEPATOLOGY, 2024, 79 (03) : E100 - E101
  • [2] Letter to the Editor: Glucocorticosteroids for Alcohol-Associated Hepatitis
    Varganova, Daria L.
    Pavlov, Chavdar S.
    Casazza, Giovanni
    Nikolova, Dimitrinka
    Gluud, Christian
    HEPATOLOGY, 2020, 71 (04) : 1524 - 1524
  • [3] Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis
    Gratacos-Gines, Jordi
    Bruguera, Pol
    Perez-Guasch, Martina
    Lopez-Lazcano, Ana
    Borras, Roger
    Hernandez-evole, Helena
    Pons-Cabrera, Maria T.
    Lligona, Anna
    Bataller, Ramon
    Gines, Pere
    Lopez-Pelayo, Hugo
    Pose, Elisa
    HEPATOLOGY, 2024, 79 (02) : 368 - 379
  • [4] Alcohol-Associated Cirrhosis
    Lucey, Michael R.
    CLINICS IN LIVER DISEASE, 2019, 23 (01) : 115 - +
  • [5] Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis: Systematic review and meta-analysis
    Lim, Wen Hui
    Tay, Phoebe
    Ng, Cheng Han
    Tan, Darren Jun Hao
    Ong, Christen
    Koh, Jia Hong
    Teng, Margaret
    Chee, Douglas
    Wong, Zhen Yu
    Kawaguchi, Takumi
    Takahashi, Hirokazu
    Muthiah, Mark
    Tan, Eunice X. X.
    Wijarnpreecha, Karn
    Lee, Guan Huei
    Noureddin, Mazen
    Lee, Brian P.
    Mathurin, Philippe
    Loomba, Rohit
    Huang, Daniel Q.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (06) : 730 - 741
  • [6] Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis
    Rabiee, Anahita
    Mahmud, Nadim
    Falker, Caroline
    Garcia-Tsao, Guadalupe
    Taddei, Tamar
    Kaplan, David E.
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (04)
  • [7] Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”
    Tatsunori Hanai
    Kayoko Nishimura
    Shinji Unome
    Takao Miwa
    Yuki Nakahata
    Kenji Imai
    Atsushi Suetsugu
    Koji Takai
    Masahito Shimizu
    Journal of Gastroenterology, 2024, 59 (12) : 1144 - 1145
  • [8] Medications for alcohol use disorder among patients with alcohol-associated cirrhosis: An underutilized intervention that could save lives
    Wakeman, Sarah E.
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (07)
  • [9] Letter to the Editor: Survival in placebo-treated patients with severe alcohol-associated hepatitis
    Van Melkebeke, Lukas
    Pollentier, Lore
    van der Merwe, Schalk
    Nevens, Frederik
    Verbeek, Jef
    HEPATOLOGY, 2023, 77 (05) : E113 - E114
  • [10] Outcomes following liver transplant for alcohol-associated liver disease: comparing alcohol-associated hepatitis and cirrhosis
    Schroeder, Matthew
    Pedersen, Mark
    Petrasek, Jan
    Grant, Lafaine
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (05)
12345